Immunovia AB (publ)

IMMVF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$109-$309-$191-$167
Dep. & Amort.$0$142$25$19
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$6$7-$7-$5
Other Non-Cash$19$14-$2$0
Operating Cash Flow-$97-$147-$176-$153
Investing Activities
PP&E Inv.$0-$1-$2-$24
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$4-$0$0
Investing Cash Flow$0$3-$2-$24
Financing Activities
Debt Repay.-$8$0$0$0
Stock Issued$52$121$1$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$7-$6-$6
Financing Cash Flow$45$115-$5-$5
Forex Effect$0-$0$1$1
Net Chg. in Cash-$51-$29-$181-$181
Supplemental Information
Beg. Cash$77$106$287$468
End Cash$25$77$106$287
Free Cash Flow-$97-$148-$177-$177